Conor McNamara
Stock Analyst at RBC Capital
(0.84)
# 3,807
Out of 4,876 analysts
123
Total ratings
23.08%
Success rate
-19.77%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Perform | $72 → $63 | $51.84 | +21.53% | 9 | May 8, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $75 → $70 | $65.01 | +7.68% | 10 | May 2, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $243.98 | +60.67% | 11 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $242.60 | +61.58% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $123.56 | +52.96% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $13.53 | +47.82% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $408.28 | +56.02% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $198.80 | +25.75% | 10 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $94.79 | +18.16% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.69 | +136.69% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $167.96 | +49.44% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.87 | +111.29% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.47 | +426.32% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.10 | +125.81% | 4 | Aug 7, 2024 |
Bio-Techne
May 8, 2025
Maintains: Sector Perform
Price Target: $72 → $63
Current: $51.84
Upside: +21.53%
Hologic
May 2, 2025
Maintains: Sector Perform
Price Target: $75 → $70
Current: $65.01
Upside: +7.68%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $243.98
Upside: +60.67%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $242.60
Upside: +61.58%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $123.56
Upside: +52.96%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $13.53
Upside: +47.82%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $408.28
Upside: +56.02%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $198.80
Upside: +25.75%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $94.79
Upside: +18.16%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.69
Upside: +136.69%
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $167.96
Upside: +49.44%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.87
Upside: +111.29%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.47
Upside: +426.32%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.10
Upside: +125.81%